Investigational Drug Information for Isavuconazole
✉ Email this page to a colleague
What is the development status for investigational drug Isavuconazole?
Isavuconazole is an investigational drug.
There have been 42 clinical trials for Isavuconazole.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 12th 2018.
The most common disease conditions in clinical trials are Aspergillosis, Mycoses, and Invasive Fungal Infections. The leading clinical trial sponsors are Basilea Pharmaceutica International Ltd, Astellas Pharma Global Development, Inc., and Astellas Pharma Inc.
There are two hundred and seven US patents protecting this investigational drug and one international patent.
Summary for Isavuconazole
| US Patents | 207 |
| International Patents | 1,770 |
| US Patent Applications | 847 |
| WIPO Patent Applications | 532 |
| Japanese Patent Applications | 13 |
| Clinical Trial Progress | Phase 3 (2018-11-12) |
| Vendors | 65 |
Recent Clinical Trials for Isavuconazole
| Title | Sponsor | Phase |
|---|---|---|
| Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi | Pfizer | Phase 4 |
| Azole-echinocandin Combination Therapy for Invasive Aspergillosis | KCE | Phase 3 |
| Azole-echinocandin Combination Therapy for Invasive Aspergillosis | Stichting Hemato-Oncologie voor Volwassenen Nederland | Phase 3 |
Clinical Trial Summary for Isavuconazole
Top disease conditions for Isavuconazole
Top clinical trial sponsors for Isavuconazole
US Patents for Isavuconazole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Isavuconazole | ⤷ Try a Trial | Engineered nucleic acids and methods of use thereof | ModernaTX, Inc. (Cambridge, MA) | ⤷ Try a Trial |
| Isavuconazole | ⤷ Try a Trial | Polynucleotides encoding immune modulating polypeptides | ModernaTX, Inc. (Cambridge, MA) | ⤷ Try a Trial |
| Isavuconazole | ⤷ Try a Trial | Mass spectrometric determination of drug resistance | ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM (NL) | ⤷ Try a Trial |
| Isavuconazole | ⤷ Try a Trial | Macrocyclic amidinourea derivatives, methods of preparation and uses thereof as chitinase inhibitors | CYGNET BIOSCIENCES B.V. (Willemstad, CW) | ⤷ Try a Trial |
| Isavuconazole | ⤷ Try a Trial | CBP/Catenin antagonists for enhancing asymmetric division of somatic stem cells | University of Southern California (Los Angeles, CA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Isavuconazole
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Isavuconazole | European Patent Office | EP2755986 | 2031-09-12 | ⤷ Try a Trial |
| Isavuconazole | World Intellectual Property Organization (WIPO) | WO2013039857 | 2031-09-12 | ⤷ Try a Trial |
| Isavuconazole | European Patent Office | EP3052106 | 2033-09-30 | ⤷ Try a Trial |
| Isavuconazole | World Intellectual Property Organization (WIPO) | WO2015048744 | 2033-09-30 | ⤷ Try a Trial |
| Isavuconazole | European Patent Office | EP2981830 | 2033-04-04 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
